ARTICLE | Product Development
EUAs for BioNTech-Pfizer, Moderna COVID-19 vaccines, readouts from AZ and J&J could come in December
Update comes as BioNTech, Pfizer vaccine posts 95% efficacy rate in preventing COVID-19
November 19, 2020 2:25 AM UTC
The U.S. government is finalizing plans for review, allocation prioritization, and distribution in December of two COVID-19 vaccines in the wake of the completion of a Phase III trial of an mRNA vaccine candidate from BioNTech and Pfizer and the imminent completion of a Phase III trial of Moderna’s mRNA vaccine candidate.
“We now have two safe and highly effective vaccines that could be authorized by the Food and Drug Administration and ready to distribute within weeks,” HHS Secretary Alex Azar told reporters at a briefing Wednesday. ...